Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

A deep generative multimodal imaging genomics framework for Alzheimer's disease prediction

Deep Generative Transfer Learning Predicts Conversion to Alzheimer'S Disease from Neuroimaging Genomics Data.

Development and validation of an interpretable deep learning framework for Alzheimer's disease classification

Multi-Modal Data Analysis for Alzheimer’s Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features

Disease‐driven domain generalization for neuroimaging‐based assessment of Alzheimer's disease

Cross-Modality Translation with Generative Adversarial Networks to Unveil Alzheimer's Disease Biomarkers

Multimodal deep learning for Alzheimer’s disease dementia assessment

Multi-Modal Diagnosis of Alzheimer's Disease using Interpretable Graph Convolutional Networks

Patch-based Interpretable Deep Learning Framework for Alzheimer’s Disease Diagnosis Using Multimodal Data

Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Integrating Genetic Information for Early Alzheimer’s Diagnosis through MRI Interpretation

Multimodal Attention-based Deep Learning for Alzheimer's Disease Diagnosis

Development and validation of a deep learning framework for Alzheimer’s disease classification

A Multimodal Learning Machine Framework for Alzheimer’s Disease Diagnosis Based on Neuropsychological and Neuroimaging Data

Multimodal Neurodegenerative Disease Subtyping Explained by ChatGPT

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms

Biomarker Investigation using Multiple Brain Measures from MRI through XAI in Alzheimer's Disease Classification

Convolutional neural network based data interpretable framework for Alzheimer’s treatment planning

Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease